Search
for
Sort by
Research 811–840 of 1000+
- AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells
- Mechanisms of autophagy and their implications in dermatological disorders
- Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3α-androstanediol and 17β-estradiol
- Gene therapy to enhance angiogenesis in chronic wounds
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Everything you want to know about androgens
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Beyond the follicle
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Tofacitinib in alopecia areata and HIV: A curious intersection of immunomodulation, hair regrowth, and hypertrichosis
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- Drug-induced scarring and permanent alopecia
- Hair loss due to aripipirazole use: a case report